Themes US Small Cap Cash Flow Champions ETF (SMCF)
Live price chart, market sentiment, and community perspectives for Themes US Small Cap Cash Flow Champions ETF (NASDAQ: SMCF).
Live price chart, market sentiment, and community perspectives for Themes US Small Cap Cash Flow Champions ETF (NASDAQ: SMCF).
On our trading desk, we are closely tracking the liquidity metrics for SMCF. With a market capitalization sitting right at $3.02 million, it firmly occupies sub-micro cap territory. While the 75-stock basket targeting 3 years of positive cash flow yield offers an intriguing value screen, execution and large-block sizing require extreme caution to avoid severe market impact costs.
Looking at the short interest data as of May 29, 2026, we see only 177 shares sold short, representing a minuscule 0.22% of the public float. This indicates an absolute absence of bearish institutional conviction or short-squeeze potential, meaning price movements are driven entirely by underlying small-value asset flows and broader market beta rather than structural positioning.
Evaluating the performance metrics, the 1-year change of 22.74% is certainly eye-catching for a small-cap value strategy. However, looking at the recent action where the price dipped 1.10% from $40.14 to $39.70, you can see how thin liquidity can exacerbate daily noise. It trades within a 52-week range of $31.82 to $41.20, showing steady upward momentum tempered by micro-cap volatility.
From a quantitative screening perspective, the mandate of focusing purely on small-cap companies with a sustained 3-year track record of positive cash flow yield is a robust filter. In our quantitative model backtests, filtering out cash-burners historically improves downside capture ratios in choppy markets, though SMCF's tiny $3.02 million AUM introduces tracking error and operational friction.
Monitoring the daily price action on NASDAQ:SMCF, the instrument recently touched a day's range between $39.59 and $39.86 before settling at $39.70. For allocators running tactical asset allocation models, this product serves as a clean, rules-based proxy for small-cap value earnings quality, provided they scale their order sizes to match the sub-micro cap liquidity profile.
Explore plasma cleansing, somatic organ swaps, and BCI.